Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 5Completed 5Recruiting 4Terminated 2Not yet recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 43Neoplasm Metastasis 5Neoplasms 4Ovarian Neoplasms 3Hereditary Sensory and Autonomic Neuropathies 3Carcinoma, Non-Small-Cell Lung 3Endometrial Neoplasms 2Carcinoma, Ovarian Epithelial 2Breast Cancer Metastatic 2Advanced Breast Cancer 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Lymphoma, Non-Hodgkin 1Hyperglycemia 1HER2-positive Metastatic Breast Cancer 1HER2-positive Breast Cancer 1Female Breast Carcinoma 1Exanthema 1Carcinosarcoma 1Carcinoma, Lobular 1Breast Neoplasms, Male 1Anatomic Stage IV Breast Cancer AJCC v8 1Adenocarcinoma Of Esophagus 1

Interventions

Letrozole 2Goserelin 2Fulvestrant 2olaparib 1abemaciclib 1Trastuzumab 1Lead 1Aromatase Inhibitors 1Anastrozole 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Advanced Breast Cancer × Fulvestrant × Clear all
NCT05085002 2026-05-14

A Study of Lerociclib in Participants With Advanced Breast Cancer

EQRx International, Inc.

Phase 2 Terminated
100 enrolled 14 charts
Breast

Advanced Breast Cancer

NCT04862143 2024-06-20

TELEPIK

Novartis

Phase 2 Terminated
2 enrolled 10 charts
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡